Clodronate Disodium

氯膦酸钠

Report date: 2024/02/21 11:59:38
NME

Base Information

Drug NameClodronate Disodium
Drug Alias Name氯屈膦酸二钠无水氯膦酸二钠氯甲双磷酸钠氯膦酸二钠Lytos +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone resorption factor inhibitors
TargetsBone resorption factor
Therapy Area/IndicationsHypercalcemiaOsteoarthritis, KneeOsteoarthritis, Hip +[5] 
Global Approved IndicationsHypercalcemiaOsteoporosisBone Diseases
Approved Indications in ChinaHypercalcemiaOsteoporosisBone Diseases
Original Approved Country/TerritoryN/A
Original Approved Date1986/01/01
Country/TerritoryItalyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSPA Società Prodotti Antibiotici SpaGuangzhou Baiyunshan Mingxing Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of Oulu
Active IndicationsHypercalcemiaOsteoarthritis, KneeOsteoporosis +[4] 
Inactive IndicationsOsteoarthritis, Hip

Other Information

ATC CodeM05BA02
Related LinksWikipediaDrugBankKEGG